Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 2 | 2022 | 49 | 1.390 |
Why?
|
| Kidney Neoplasms | 2 | 2022 | 80 | 1.360 |
Why?
|
| DNA, Mitochondrial | 2 | 2025 | 191 | 0.730 |
Why?
|
| Repressor Proteins | 2 | 2022 | 273 | 0.730 |
Why?
|
| Prostatic Neoplasms | 4 | 2025 | 1092 | 0.690 |
Why?
|
| Mitochondria | 2 | 2018 | 523 | 0.480 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 31 | 0.430 |
Why?
|
| Proteome | 1 | 2014 | 152 | 0.390 |
Why?
|
| Estradiol | 1 | 2014 | 268 | 0.370 |
Why?
|
| Proteomics | 1 | 2014 | 378 | 0.360 |
Why?
|
| Prognosis | 2 | 2022 | 861 | 0.290 |
Why?
|
| Pancreatic Neoplasms | 2 | 2025 | 218 | 0.290 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 37 | 0.230 |
Why?
|
| Microglia | 2 | 2018 | 208 | 0.220 |
Why?
|
| Male | 10 | 2025 | 23409 | 0.220 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 67 | 0.210 |
Why?
|
| Genomics | 1 | 2025 | 293 | 0.190 |
Why?
|
| Zinc Fingers | 1 | 2022 | 28 | 0.190 |
Why?
|
| Mammals | 1 | 2022 | 112 | 0.180 |
Why?
|
| Databases, Genetic | 1 | 2021 | 103 | 0.170 |
Why?
|
| Humans | 11 | 2025 | 43102 | 0.170 |
Why?
|
| Survival Rate | 1 | 2021 | 355 | 0.160 |
Why?
|
| Biomedical Research | 2 | 2024 | 502 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2018 | 239 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 60 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 2853 | 0.140 |
Why?
|
| Hydrolyzable Tannins | 1 | 2018 | 20 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 149 | 0.130 |
Why?
|
| Butyric Acid | 1 | 2017 | 19 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2017 | 14 | 0.130 |
Why?
|
| Interferon-gamma | 1 | 2018 | 269 | 0.130 |
Why?
|
| Valproic Acid | 1 | 2017 | 21 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2022 | 735 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 140 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2017 | 33 | 0.130 |
Why?
|
| Contrast Media | 1 | 2017 | 103 | 0.130 |
Why?
|
| Female | 6 | 2025 | 24698 | 0.130 |
Why?
|
| Liposomes | 1 | 2017 | 132 | 0.130 |
Why?
|
| Health Status Disparities | 2 | 2014 | 719 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 196 | 0.120 |
Why?
|
| Life Style | 1 | 2018 | 334 | 0.120 |
Why?
|
| Manganese | 1 | 2017 | 92 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1124 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 532 | 0.120 |
Why?
|
| Aged | 3 | 2025 | 8214 | 0.120 |
Why?
|
| Cell Survival | 3 | 2015 | 945 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2018 | 358 | 0.120 |
Why?
|
| Astrocytes | 1 | 2017 | 244 | 0.110 |
Why?
|
| Benzoquinones | 1 | 2015 | 47 | 0.110 |
Why?
|
| Middle Aged | 4 | 2025 | 12222 | 0.110 |
Why?
|
| Motor Activity | 1 | 2017 | 437 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 1234 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 269 | 0.110 |
Why?
|
| Neoplasms | 2 | 2024 | 1377 | 0.100 |
Why?
|
| Florida | 3 | 2024 | 478 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 587 | 0.100 |
Why?
|
| Young Adult | 3 | 2021 | 5080 | 0.100 |
Why?
|
| Testosterone | 1 | 2014 | 211 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 187 | 0.100 |
Why?
|
| Animals | 6 | 2022 | 16992 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2676 | 0.090 |
Why?
|
| Adult | 4 | 2025 | 13872 | 0.090 |
Why?
|
| Education, Pharmacy | 1 | 2012 | 57 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2012 | 156 | 0.080 |
Why?
|
| Apoptosis | 1 | 2018 | 1568 | 0.080 |
Why?
|
| Cultural Competency | 1 | 2012 | 138 | 0.080 |
Why?
|
| Students, Pharmacy | 1 | 2012 | 58 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1019 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1455 | 0.070 |
Why?
|
| Minority Groups | 2 | 2024 | 690 | 0.070 |
Why?
|
| United States | 3 | 2025 | 5205 | 0.060 |
Why?
|
| Leukocytes | 1 | 2025 | 80 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2025 | 95 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 989 | 0.050 |
Why?
|
| Oxidopamine | 1 | 2004 | 23 | 0.050 |
Why?
|
| Glycolysis | 1 | 2004 | 71 | 0.050 |
Why?
|
| Education, Distance | 1 | 2024 | 46 | 0.050 |
Why?
|
| Research Personnel | 1 | 2024 | 206 | 0.050 |
Why?
|
| California | 1 | 2024 | 548 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1285 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2025 | 1759 | 0.040 |
Why?
|
| Universities | 1 | 2024 | 559 | 0.040 |
Why?
|
| Mutation | 1 | 2025 | 1177 | 0.040 |
Why?
|
| Mice | 3 | 2018 | 6644 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2004 | 1003 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 28 | 0.030 |
Why?
|
| Viscosity | 1 | 2017 | 46 | 0.030 |
Why?
|
| Gadolinium | 1 | 2017 | 30 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 95 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 129 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2017 | 38 | 0.030 |
Why?
|
| Cerebellum | 1 | 2017 | 79 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2017 | 141 | 0.030 |
Why?
|
| Particle Size | 1 | 2017 | 272 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 408 | 0.030 |
Why?
|
| Students | 1 | 2021 | 626 | 0.030 |
Why?
|
| Nitrites | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 95 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 306 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 277 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 119 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2015 | 128 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 1410 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 49 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 249 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 712 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 458 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 458 | 0.020 |
Why?
|
| Health Surveys | 1 | 2014 | 405 | 0.020 |
Why?
|
| Schools, Pharmacy | 1 | 2012 | 19 | 0.020 |
Why?
|
| Awareness | 1 | 2012 | 73 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1869 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 460 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2012 | 60 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 2012 | 128 | 0.020 |
Why?
|
| Prejudice | 1 | 2012 | 116 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 678 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Cultural Diversity | 1 | 2012 | 193 | 0.020 |
Why?
|
| Language | 1 | 2012 | 185 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1070 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 231 | 0.020 |
Why?
|
| Curriculum | 1 | 2012 | 318 | 0.020 |
Why?
|
| Child | 1 | 2014 | 3443 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2004 | 35 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3156 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 6081 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 457 | 0.010 |
Why?
|